Cantor Fitzgerald analyst Ross Osborn downgraded Mainz Biomed B.V. (NASDAQ: MYNZ) from Overweight to Neutral.The analyst commented, "We are lowering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE